How large is the 3d cell culture technologies market, and what is its growth trajectory?
The 3D cell culture technologies market size has grown rapidly in recent years. It will grow from $3.36 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to advancements in cell biology, drug development, rising incidence of chronic diseases, government funding.
The 3D cell culture technologies market size is expected to see exponential growth in the next few years. It will grow to $8.33 billion in 2029 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to pharmaceutical industry, increasing research and development, environmental and ethical considerations. Major trends in the forecast period include personalized medicine, technological advancements, bioprinting, regenerative medicine.
Get Your Free Sample of The Global 3D Cell Culture Technologies Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2462&type=smp
What are the key forces behind the 3d cell culture technologies market’s growth in recent years?
The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. For instance, in January 2023, according to United Network for Organ Sharing (UNOS), a US-based non-profit organization, In 2022, 42,887 organ transplants were performed in the United States, an increase of 3.7% over 2021. A total of 14,903 people became deceased organ donors nationwide in 2022, representing the twelfth consecutive record year for deceased donations and an increase of 7.5% over 2021. As the medical criteria for deceased organ donation continue to broaden based on favorable clinical experience, increasing proportions of donors come from less traditional categories of eligibility. In 2022, 4,776 people donated after circulatory death (DCD donors) as opposed to brain death, representing an increase of nearly 14% over the 2021 total. There were 5,789 deceased donors aged 50 or older, the first time there have been more than 5,000 donors of that age range in a single year.
What are the major segments of the 3d cell culture technologies market?
The 3D cell culture technologies market covered in this report is segmented –
1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors
2) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine
3) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users
Subsegments:
1) By Scaffold-Based: Natural Scaffolds, Synthetic Scaffolds, Hybrid Scaffolds
2) By Scaffold-Free: Spheroid-Based, Organoid-Based
3) By 3D Bioreactors: Spinner Flask Bioreactors, Rotating Wall Bioreactors, Microcarrier-Based Bioreactors, Hollow Fiber Bioreactors
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report
Which companies dominate the 3d cell culture technologies market?
Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.
What major trends will shape the 3d cell culture technologies market during the forecast period?
Implementing the latest technology is the latest trend in the 3D Cell culture market. For example, various companies have adopted one such advancement in the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek’s 3D cell expansion system to be used as a medical device. It also approved Biotek’sPolycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA-approved implants and drug delivery devices.
What are the key regional dynamics of the 3d cell culture technologies market, and which region leads in market share?
North America was the largest region in the 3D cell culture technologies market in 2023. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3D cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The 3D Cell Culture Technologies Market Report 2025 Offer?
The 3d cell culture technologies market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cell culture is a process for developing substrates for the safe production of viral vaccines. 3D cell culture is an in vitro technique wherein the cells can grow in an artificially created environment. These technologies are essential for understanding more complex biological processes, such as tissue development, cell behavior, drug responses, and disease mechanisms.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2462
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
